These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21115778)

  • 21. Cardiac risk factors and hypoglycemia in an elderly patient: how good is good enough?
    Triplitt C
    Consult Pharm; 2010 Jun; 25 Suppl B():19-27. PubMed ID: 20726379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial.
    Yang L; Ling W; Yang Y; Chen Y; Tian Z; Du Z; Chen J; Xie Y; Liu Z; Yang L
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28994705
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
    Füchtenbusch M; Hummel M
    MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comment from the diabetology viewpoint].
    Stahl M
    Praxis (Bern 1994); 2008 Aug; 97(17):943-4. PubMed ID: 18777777
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daily glycaemic variability: benefits of optimal control.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():1-2. PubMed ID: 24034512
    [No Abstract]   [Full Text] [Related]  

  • 27. Tight blood glucose control.
    Frank SJ
    Geriatrics; 2008 Oct; 63(10):3; author reply 3. PubMed ID: 18828649
    [No Abstract]   [Full Text] [Related]  

  • 28. Tight blood glucose control.
    Bloomgarden ZT
    Geriatrics; 2008 Oct; 63(10):3; author reply 3. PubMed ID: 18828648
    [No Abstract]   [Full Text] [Related]  

  • 29. Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia.
    Cryer PE
    Diabetes; 2014 Jul; 63(7):2188-95. PubMed ID: 24962915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A New Algorithm Dedicated to Blood Glucose Monitoring in Insulin-Treated Elderly Dependent People With Diabetes.
    Grino M; Loundou A; Boucekine M; Alitta Q; Oliver C
    J Diabetes Sci Technol; 2019 Mar; 13(2):410-412. PubMed ID: 30537870
    [No Abstract]   [Full Text] [Related]  

  • 31. Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus.
    Cheung NW; Conn JJ; d'Emden MC; Gunton JE; Jenkins AJ; Ross GP; Sinha AK; Andrikopoulos S; Colagiuri S; Twigg SM;
    Med J Aust; 2009 Sep; 191(6):339-44. PubMed ID: 19769558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic control and cardiovascular disease: what's a doctor to do?
    Kishore P; Kim SH; Crandall JP
    Curr Diab Rep; 2012 Jun; 12(3):255-64. PubMed ID: 22467273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes. Paradoxical effects of tightly controlled blood sugar.
    Taubes G
    Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
    Wareham NJ; Pfister R
    Nat Rev Cardiol; 2010 Jul; 7(7):367-8. PubMed ID: 20577298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The burden of post-prandial hyperglycemia and its implications.
    Shah SN; Das AK
    J Assoc Physicians India; 2001 Jan; 49 Spec No():1-2. PubMed ID: 11245155
    [No Abstract]   [Full Text] [Related]  

  • 36. [Monitoring of the insulin treated diabetic].
    Soltani D; Perlemuter L
    Presse Med; 1998 Jul 4-11; 27(24):1251-4. PubMed ID: 9767789
    [No Abstract]   [Full Text] [Related]  

  • 37. Managing your blood glucose ups and downs.
    Griffin S; Ballard D
    Diabetes Self Manag; 2009; 26(1):36, 38, 41-2 passim. PubMed ID: 19213144
    [No Abstract]   [Full Text] [Related]  

  • 38. Should A1C targets be individualized for all people with diabetes? Arguments for and against.
    Teoh H; Home P; Leiter LA
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S191-6. PubMed ID: 21525454
    [No Abstract]   [Full Text] [Related]  

  • 39. [Different strategies in prediabetes, new and long-time diabetes. What therapy for what diabetics?].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Jan; 152(3):12-4, 16. PubMed ID: 20333958
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial.
    Miller ME; Williamson JD; Gerstein HC; Byington RP; Cushman WC; Ginsberg HN; Ambrosius WT; Lovato L; Applegate WB;
    Diabetes Care; 2014; 37(3):634-43. PubMed ID: 24170759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.